Whether in infectious diseases (COVID-19, Sepsis, Zika), immuno-oncology, auto-immune, inflammatory disorders, evaluating innovative immunotherapies (ICPI) or cell therapies (CAR-T cells), uncontrolled release of cytokines, known as cytokine storm, may be life-threatening for patients. Detecting harmful levels of cytokines is a matter of life or death for patients, and crucial for adapting patient care.

As an expert in soluble biomarker analysis, ABL is a partner of choice to support you overcome these challenges.

Discover the Ella system:

- Fully automated fluidic immunoassay platform

- Validated standard curve included within the cartridge

- Multi-analytes possible with NO multiplexing: up to 8 analytes can be analyzed seperately limitating antibody cross-reactivity

- Sub-picogram level sensitivity, 4+ logs of dynamic range and high reproducibility

- Very low sample volume: 2.5 to 25 µL per duplicate and triplicate

- Customizable cartridges for building your own assays

- High throughput : up to ~300 samples a day

- Extended catalogue: 190+ soluble mediators available

Your one-stop-shop for monitoring host immune responses to pathogens

Is this time unprecedented, unpredictable, scary ? Yes but

In the scientific community we trust!

Leverage the robustness of MSD Multi-array® technology to get SENSITIVE and RELIABLE RESULTS for your BIOMARKER and IMMUNOGENICITY assays!

Contact us to learn more about MSD technology and our full suite of services.